Lobbying Activity Report

1576-21840

Organization: GlaxoSmithKline Inc.
Associated registration: 9014-1576-25
Lobbying Activity date: 2022-10-03
Arranged a meeting: No
Posted date: 2022-11-15

In-house lobbyists who participated in the lobbying activity: Peter Fonyondi
Laura Fitzgerald
Bryan Tennant
Senior Public Office Holders who were lobbied in this activity: Shirley Bond, MLA for Prince George-Valemount
Member(s) of the BC Legislative Assembly Footnote1

Kevin Falcon, MLA for Vancouver-Quilchena
Member(s) of the BC Legislative Assembly Footnote1

Marissa Olsen, Research, Operations and Communications Coordinator
Liberal Caucus Research, Member(s) of the BC Legislative Assembly Footnote1
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discussions regarding pharmaceutical and vaccine procurement, drug and vaccine listings on publicly funded programs and other issues related to access to GSK medicines
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 COVID-19, Economic Development and Trade, Government Procurement, Health, Industry
GSK will conduct activities related to advancement of GSK medicines and vaccines with stakeholders of the healthcare system.
  • Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
  • Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 COVID-19, Economic Development and Trade, Health, Hospitals, Industry
Meeting with Government and Healthcare officials to discuss pharmaceutical and health policy, economic development as it relates to clinical trials and other research, scientific information related to GSK's portfolio of medicines and vaccines.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 COVID-19, Economic Development and Trade, Health, Hospitals, Intellectual Property, Science and Technology
 
Senior officer who filed this Lobbying Activity Report: Zacharie Gana
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Date Modified: